We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of UHT Treated Milk on Blolipid Profile (UHT)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2012 by AAstrup, University of Copenhagen.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01753700
First Posted: December 20, 2012
Last Update Posted: December 20, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Arla Foods
Hoeng Fonden
Bionor Pharma
Information provided by (Responsible Party):
AAstrup, University of Copenhagen
  Purpose
The studie are to investigate the effect of ultra heat treated (UHT) versus pasteurised milk on bloodlipid profile

Condition Intervention
To Investigate the Effect of UHT Treated Milk Versus Pasteurised Milk on Bloodlipid Profil Dietary Supplement: UHT treated milk

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Effect of UHT Treated Milk on Blolipid Profile

Further study details as provided by AAstrup, University of Copenhagen:

Primary Outcome Measures:
  • Blood lipids [ Time Frame: 3 weeks ]

Estimated Enrollment: 20
Study Start Date: December 2012
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: UHT treated milk
1,5 L of 1,5% UHT milk pr day for 3 weeks (21days)
Dietary Supplement: UHT treated milk
Placebo Comparator: Paseurised milk
1,5 L 1,5% pasteurised milk pr day for 3 weeks (21 days)
Dietary Supplement: UHT treated milk

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   22 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy men and women
  • 22-50 years of age
  • BMI 25-30
  • non smokers

Exclusion Criteria:

  • lactose intolerance
  • milk allergy or other types of food allergy
  • Intestinal, abdominal or endocrinnologic diseases
  • daily use of dietary supplements incl. vitamins and minerals
  • cronic diseases (diabetes, CVD etc.)
  • user of medicin on perscription that can influence the resuts of the study
  • allergic to paraamino benzoe acid
  • Physical activity > 10 h pr week
  • Blood donor
  • on a diet or change of dietary habits within 3 months
  • body weigh change > 3 kg within the last 3 month
  • special diets
  • concomitant participation on other studies
  • not able to comply with protocol
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01753700


Locations
Denmark
Department of Nutrition, Exercise and Sports Recruiting
Copenhagen, Frederiksberg, Denmark, 1958
Contact: Janne Lorenzen, Ass.Prof.    25324572 ext +45    jakh@ife.ku.dk   
Contact: Karina Sorensen, Msc    51680399 ext +45    karvs@ife.ku.dk   
Principal Investigator: Janne K Lorenzen, Ass. Proff.         
Sponsors and Collaborators
University of Copenhagen
Arla Foods
Hoeng Fonden
Bionor Pharma
  More Information

Responsible Party: AAstrup, MD, University of Copenhagen
ClinicalTrials.gov Identifier: NCT01753700     History of Changes
Other Study ID Numbers: B300
First Submitted: December 17, 2012
First Posted: December 20, 2012
Last Update Posted: December 20, 2012
Last Verified: December 2012

Keywords provided by AAstrup, University of Copenhagen:
crossover
UHT milk
Pasteurised milk
supplement